Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Official title:
BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease
Charcot Marie Tooth (CMT) is the most common inherited neuropathy. It affects the nerves of the hands and feet first, slowly progressing towards the centre of the body. It causes varying degrees of weakness and reduced feeling, usually affecting the feet and ankles first. High incidence of falls and knock on effects in quality of life are common. This is a lifelong condition which, though not life limiting, does not have a cure. Research into the effect of balance rehabilitation in people with CMT has been limited to traditional exercises, which do not address the complex nature of balance impairments in this condition. Multi-sensory rehabilitation has proved beneficial in improving balance in people with sensory neuropathy. Research shows that strengthening trunk muscles can improve balance in older people. Trunk and muscles close to it are largely unaffected in people with CMT, therefore these muscles could be strengthened in these patients. This study proposes to assess the feasibility of multi-sensory balance training, strength training with a focus on the trunk and muscles close to the trunk, and falls management education. This comprehensive approach is reflective of a clinical physiotherapy programme. Though a life-long condition, many people with CMT lead full lives. A home based programme is proposed to so that patients can fit it into their lives without having to travel for treatment. Therapists will use self-management principles within treatment. Measurements will be taken prior to and following treatment including physical measures, questionnaires and interviews. The physiotherapy interventions will be taught home and data collection will be at the National Hospital for Neurology and Neurosurgery, University College London Hospitals (UCLH).
A recent, unpublished focus group study of people with CMT found that they reported more
falls than healthy people. They reported problems walking on uneven surfaces, difficulty
getting off the floor and a necessity to consciously think about every step to avoid falling
while walking (GM Ramdharry et al., 2015). A retrospective survey of people with CMT found
that 89% of the 94 respondents reported falls to the ground. Half of them reported falling at
least once a month with 5% falling every day (Ramdharry et al., 2011). We have just completed
an exploratory study of factors predicting falls risk. Preliminary analysis of prospective
falls data for 32 people over 6 months showed that they fell a median of 4 times (range 0 -
54 falls) and functional balance performance may be predictive (Ramdharry et al., 2015). A
study of people with CMT1a found that sensory impairment increased visual dependence for a
static balance task (van der Linden et al., 2010). There has only been one small study of
balance training in people with CMT, comparing a novel rehabilitation device with more
traditional exercises (Matjacić and Zupan, 2006). Both interventions showed improvement in
functional balance scores. Studies of proximal strength training in CMT have shown
improvements in walking parameters (Chetlin et al., 2004; Lindeman et al., 1995), but the
effect on balance has not been explored. Because of the mixed sensori-motor presentation of
people with CMT, a combined approach of multi-sensory balance training and proximal
strengthening will be delivered. A home-based model has been proposed as CMT is a life-long
condition that needs to be managed by the individual outside of the medical or therapy
environment.
STUDY DESIGN & JUSTIFICATION A single blinded randomised controlled design has been chosen in
this feasibility study. The intention is to see if there is an effect of the intervention to
later be explored in a larger randomized controlled trial. A blinded assessor will measure
balance performance prior to randomisation and following the 12 weeks of either intervention
or control. They will also undertake qualitative interviews prior to randomization and
following final measurement session. Interviews will inform the intervention and its
acceptability. All participants will receive a falls assessment and falls education.
Following randomisation, participants will either receive the 12-week intervention or control
period. The intervention will include a holistic programme of physiotherapy including
strength training of muscle groups unaffected by the condition and multi-sensory exercises to
target balance. The program will be delivered by a physiotherapist trained in delivering
treatment under the principles of self-management. Exercises will be carried out by the
patients in their own homes and monitored by the research physiotherapist, progressing as
appropriate. Those randomized to the control arm will receive monitoring telephone calls
throughout this 12-week period.
RECRUITMENT Patients will be recruited from outpatient neurology clinics at Queen Square
which specialise in the diagnosis and management of CMT. Patients who fit the inclusion
criteria will be approached and the trial will be described to them. Written information will
be provided and arrangement made for a way to make contact once they have decided about
whether they wish to proceed with screening. All patients who agree to proceed will go
through a screening which will take place over the telephone. Those who pass screening will
be provided with falls diary postcards or arrangement for falls diary emails, which they will
be asked to monitor and report for one month. A sample will be invited for a qualitative
interview. Arrangement will be made for them to attend a baseline measurement session, falls
assessment, and falls education following the month-long falls monitoring.
Measures will include:
Patient reported questionnaires of balance confidence, mood, walking ability and physical
functioning 10m walk test / 6 minute walk test Berg Balance Scale Bruininks Oseretsky Test
(BOT) BESTest Functional balance tests using force plate and movement analysis equipment
Strength testing of the lower limbs and hands Charcot Marie Tooth Examination Score (CMTES) A
block randomisation will occur following the baseline measurement and falls education session
with allocation either being to a control arm or an intervention arm. This will be done by
the PI or research physiotherapist who will remain un-blinded. Contact with the blinded
assessor will cease until the final measurement session 12 weeks later.
INTERVENTION:
If randomised to the control arm of the study, participants will be advised that the research
physiotherapist will contact them monthly to monitor any falls or issues. For those
randomised to the intervention arm, a home visit will be arranged with the research
physiotherapist as soon as possible. During this session, the research physiotherapist will
provide the participant with exercises to strengthen the muscles of the trunk and proximal
muscles using body weight and graded ankle weights. Strength training will be performed 4
times per week. They will also give a selection of exercises targeting balance to challenge
stability and sensory feedback. Participants will be asked to perform balance exercises
daily. A risk assessment will be undertaken with guidance on how to ensure safety when doing
the exercises. An exercise diary will be provided for the participants to monitor exercise
frequency.
Arrangements will be made for weekly telephone calls with the research physiotherapist to
monitor progress and a provisional date set for the first monthly home monitoring visit.
Participants in the intervention arm will be contacted weekly for 12 weeks on the study. The
research physiotherapist will visit them at home to monitor and progress exercises once a
month during this time.
QUALITATIVE RESEARCH At the consent meeting all patients will be invited to take part in
interviews conducted after the consent meeting and following completion of the final
measurements. They will be made aware that participation in the interviews is supplementary
to the main study and they are free to decline. Purposive sampling will be used to ensure a
sample of maximum diversity of age, gender, and symptom severity. Potential qualitative
interview participants will be given written details of the qualitative study and asked to
give their consent to be interviewed if they are willing to take part. The interview will be
audio recorded and consist of a dialogue between the interviewer (the researcher) and the
participant. A topic guide will be used during the interviews, but the participant will be
invited to raise issues of importance to them. Data analysis will be iterative, in that it
will be continually analysed throughout the data collection process and used to inform
following interviews.
PROCEDURES TO DEAL WITH RESEARCHER EFFECTS AND BIAS Assessments will be carried out by a
blinded assessor to standardise treatment during tests. Falls assessment and falls education
will be provided at the baseline measurement session by the blinded assessor, prior to
participant randomisation. In this way participants will be given the same treatment. The
blinded assessor will perform final measurements. The participant will be reminded prior to
the start the final session to not mention what they may or may not have been doing in the 12
weeks prior to maintain blinding throughout the session
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03550300 -
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study
|
||
Recruiting |
NCT05902351 -
Natural History Study for Charcot Marie Tooth Disease
|
||
Active, not recruiting |
NCT03023540 -
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
|
Phase 3 | |
Completed |
NCT05333406 -
Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A
|
Phase 1 | |
Completed |
NCT03386266 -
Biomarkers and Validation of Selected Outcome Measures (CMTNSmod)
|
||
Not yet recruiting |
NCT03397303 -
Quantification of Nerve Stiffness in Neuropathies
|
N/A | |
Completed |
NCT00484510 -
High Dose Ascorbic Acid Treatment of CMT1A
|
Phase 2/Phase 3 |